Strameno Ltd., Salisbury, Wiltshire, United Kingdom and AlgiSys Biosciences Inc. Cleveland, Ohio, USA today announced that they have entered a Memorandum of Understanding.
Strameno and AlgiSys are both working at the cutting edge of algae technologies, which can have significant impacts on human and animal health while addressing the catastrophic problem of overfishing. The partnership will enable both companies to leverage their complementary expertise and knowledge by creating new products to supply an ever-expanding market for omega-3s, antioxidants, and plant protein.
Dr. Lydia Brown, Strameno Director, noted: “We’re excited to be working with AlgiSys. Our expertise in DHA and niche algae strains combined with AlgiSys expertise in algae commercialization and fermentation technology will help us scale and reach an increasingly wider audience of consumers interested in the many nutritional and health benefits of algal ingredients and products.”
Dr. Charles Roe, AlgiSys CTO, added: “Strameno’s deep knowledge and expertise in microalgae and DHA is unparalleled. Their ultra-high DHA strain of microalgae is a perfect complement to our fermentable strains of microalgae containing EPA omega-3. Working with their team will allow us to expand beyond EPA into carotenoids and DHA for all our targeted vertical markets.”
Strameno Ltd. was created in 2018 to commercialize science that was started decades earlier. The company was founded by a team of scientists working with Strameno’s patented strains of microalgae found in the marine environments of the UK and Scotland. Very little was known about these organisms, which were independently and continuously sub-cultured for their omega-3 and carotenoid content. Strameno is working to develop these strains, which have great potential for algal oils and other important algae-based products. https://www.strameno.com
AlgiSys BioSciences, Inc. is a disruptive BioFoodTech company with patented microalgae-based omega-3 and protein solutions for multiple high-growth markets. AlgiSys uses commercial fermentation technology to sustainably produce non-GMO, halal, vegan, EPA Omega-3s and plant protein. AlgiSys’ all-natural products are a traceable and a complete technology solution that can replace fish oil and fishmeal as a source for human nutrition, pet and animal health, aquaculture, cosmetics, and pharmaceuticals. https://www.algisys.com
For further information:
Strameno – Dr. Lydia Brown – admin@strameno.com
AlgiSys BioSciences – Roger Frank – roger.frank@algisys.com